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Introduction {#sec005}
============

Primary bloodstream infections (PBSI) in intensive care units (ICU) are associated with high mortality. This mortality is related to patient factors (sex, age and underlying diseases), adequate antibiotic therapy ICU factors (staff to patient ratios, safety climate, etc.) and the pathogens responsible. Some pathogens (e.g. *P*.*aeruginosa*) and some multi-drug resistant variants of pathogens (e.g. multiresistant *A*.*baumannii*) are known to be associated with significantly higher ICU mortality \[[@pone.0194210.ref001]--[@pone.0194210.ref003]\]. However, such information is not available for many other pathogens that frequently cause primary bloodstream infections (PBSI).

The reason for this lack of information is the need to analyze large numbers of PBSI cases. In addition, it would be preferable to diagnose infections by applying definitions designed for surveillance and not those derived from other databases, e.g. discharge data. Furthermore, information about the most important risk factors needs to be available, including the time interval between ICU admission and the onset of infection. Therefore, only a few studies have been able to provide comparable information about mortality based on the type of pathogen \[[@pone.0194210.ref003]--[@pone.0194210.ref008]\]. Many included only a small number of species or did not consider information for such frequently occurring pathogens like *E*.*coli* or Enterococci.

The ICU component of the German National Nosocomial Infection Surveillance System (KISS) includes a large number of ICUs \[[@pone.0194210.ref009]\]. In the case of healthcare-associated PBSI, it records not only the type of pathogen isolated from relevant microbiological samples, but also the time from admission to the ICU until occurrence of PBSI. This database allows the analysis of differences between various pathogens that cause PBSI in ICUs in ICU mortality.

The objective of this study is to determine the impact of the type of pathogen on ICU mortality following a ICU-acquired PBSI.

Material and methods {#sec006}
====================

Ethics statement {#sec007}
----------------

All data was anonymous and was collected in accordance with the German recommendations for good epidemiological practice with respect to data protection ((DAE) AEMdDAE (2013) Leitlinien und Empfehlungen zur Sicherung von Guter Epidemiologischer Praxis (GEP): <http://www.gesundheitsforschung-bmbf.de/_media/GEP.pdf>. Accessed 05 May 2017). A federal law, the German Protection against Infection Act (Infektionsschutzgesetz §23) regulates the prevention and management of infectious disease in humans. All hospitals are obliged to continuously collect and analyse healthcare-associated infections and drug-resistant pathogens (German Protection against Infection Act. \"Gesetz zur Verhütung und Bekämpfung von Infektionskrankheiten beim Menschen\" (2013): <http://www.gesetze-im-internet.de/ifsg/index.html>. Accessed 05 May 2017). This data is reported regularly to the National Reference Centre for the Surveillance for Nosocomial Infections. Ethical approval and informed consent were, therefore, not required.

Data collection {#sec008}
---------------

Surveillance data from a ten-year period from January 2006 until December 2015 was used for the analysis. ICU-KISS is a unit-based surveillance system like the ICU component of the American National Healthcare Safety Network (NHSN). During this period, CDC definitions were used to diagnose PBSI \[[@pone.0194210.ref010]\]. A primary BSI was defined as a positive blood culture with one (or more) pathogen(s) which was not related to an infection on another site. For a BSI with skin germs, for example with coagulase negative Staphylococci (CNS), the definition also requires further clinical signs and the physician starts according to an antibiotic therapy. However, beginning in 2011 a new CDC definition of PBSI with skin germs was introduced \[[@pone.0194210.ref011]\]. Since that time two separate blood cultures are required for skin germs in combination with other clinical signs. The PBSI was defined as CVC-associated when the patient that had a CVC at the time of or within 48 hours before onset of the infection.

In the case of an ICU-acquired PBSI, the surveillance staff has to record the time to BSI, the ICU mortality and the pathogens identified in the blood culture. Up to four pathogens can be recorded per infection. Only mono-microbial infections were considered in the analysis. The 13 most common organisms causing PBSI were analyzed individually: coagulase negative Staphylococci (CNS), Enterococcus *spp*., *S*.*aureus*, *C*.*albicans*, non-albicans-Candida *spp*., *E*.*coli*, Klebsiella *spp*., Enterobacter *spp*., *P*.*aeruginosa*, Serratia *spp*., Acinetobacter *spp*., Proteus *spp*., and *S*.*maltophilia*. All other pathogens were analyzed as type "other". In addition, for the 13 organisms specified we categorized the organisms into the pathogen groups (gram-positive/gram-negative bacteria/fungi) and multi-drug resistance groups (non-MDR/MDR). MDR was defined as Methicillin resistant for *S*.*aureus*, Vancomycin resistant for *E*.*faecalis* and *E*.*faecium*, and a resistance to at least three antibiotic groups for *P*.*aeruginosa*, Acinetobacter *spp*., Enterobacter *spp*., *E*.*coli*, *S*.*maltophilia*, Klebsiella *spp*. and/or the resistance mechanisms ESBL for *K*.*pneumonia* and *E*.*coli*.

Statistical analysis {#sec009}
--------------------

In our analysis, the primary outcome was ICU mortality following ICU-acquired PBSI. Univariable and multivariable risk factor analyses were performed to identify organisms *(pathogen groups and/or multidrug resistance groups)* associated with increased or decreased risk of ICU mortality as well as additional related factors and confounders, such as sex (male/female), age group (≤45/46-55/56-65/66-75/\>75years), time from admission to the ICU until onset of PBSI(days), CVC associated with PBSI (no/yes), type of ICU (8 categories), size of ICU (\</≥12 beds), type of hospital (tertiary care yes/no), and size of hospital (\</≥600 beds), season(Dec-Feb/Mar-May/Jun-Aug/Sep-Nov) and long-term time trends (year). In the univariable analysis, differences were tested by Chi-Square test or Wilcoxon rank-sum test. Parameters with more than two categories were tested as binary parameters.

In the multivariable analysis, a logistic regression analysis was performed. Since observations within an ICU are not statistically independent due to varying patient populations (especially the treatment management), adjusted odds ratios (OR) with 95% confidence intervals (CI) were calculated. They were based on generalized estimating equation (GEE) models which account for this clustering effect by using an exchangeable correlation structure. The multivariable model building strategy was performed stepwise backward, from a full model with all parameters, non-significant parameters were excluded with the significance level of p = 0.05 for excluding a parameter from the model in the type III test. *S*.*aureus* was used as reference micro-organisms because this pathogen frequently causes PBSI, and it is very likely that, when detected in a blood culture, it is the responsible pathogen, in contrast to coagulase negative Staphylococci, which are often regarded as skin contaminants. In addition, experts agree that *S*.*aureus* is a common cause of severe bloodstream infections, and mortality and morbidity of *S*.*aureus* bacteremia still remain considerably high \[[@pone.0194210.ref012]--[@pone.0194210.ref013]\]. Furthermore, other studies have provided substantial information about *S*.*aureus* mortality which can be used for comparison \[[@pone.0194210.ref008]\], \[[@pone.0194210.ref014]\]. For epidemiological reasons, age group and sex were included in all models. P-values less than 0.05 were considered significant.

Beside age, gender and time to PBSI, no more individual patient-based parameters are available in the multivariable analysis which describe the severity of illness of the patients. However, structure parameters, such as type and size of ICU, and type and size of the hospital where the ICU is located, were considered in the multivariable analysis.

In addition, to better characterize risk potential of patients, we conducted a further multivariable analysis which considered the monthly mean of length of stay (LOS), device use (central venous catheter, invasive ventilation and urinary tract catheter) and bed occupation of the ICU in which the PBSI occurs. These results do not differ from the results without these parameters. Therefore, we present the results without these parameters.

All analyses were performed using SPSS \[IBM SPSS statistics, version 23, Somer, NY, USA\] and SAS 9.4 \[SAS Institute, Cary, NC, USA\].

Results {#sec010}
=======

A total of 4,556,360 patients with 16,978,882 patient days from 937 ICUs (\> = 1 PBSI) were considered in the analysis. [Table 1](#pone.0194210.t001){ref-type="table"} describes the characteristics of the ICUs included.

10.1371/journal.pone.0194210.t001

###### Characteristics of 973 intensive care units (ICU) included in the study, ICU-KISS, 2006--2015.

![](pone.0194210.t001){#pone.0194210.t001g}

  Parameter                     Description                                    Number   Percentage
  ----------------------------- ---------------------------------------------- -------- ------------
  ICUs                          total                                          937      100.0%
  Surveillance time of ICU      Months (median, IQR)                           56       30--95
  Size of ICU                   ICU beds (median, IQR)                         12       8--15
  Size of hospital              Hospital beds (median, IQR)                    439      270--749
  Type of hospital              Non tertiary care                              659      70.4
                                Tertiary care                                  278      29.6
  Type of ICU                   Interdisciplinary                              495      52.8%
                                Medical                                        140      14.9%
                                Surgical                                       162      17.3%
                                Neurosurgical                                  24       2.6%
                                Cardiosurgical                                 26       2.8%
                                Neurological                                   19       2.0%
                                Pediatric                                      26       2.8%
                                Other [^a^](#t001fn002){ref-type="table-fn"}   45       4.8%
  Length of stay                Days (median, IQR)                             3.7      2.9--5.3
  CVC utilization rate          CVC days per 100 pd (median, IQR)              65.9     51.0--79.8
  Ventilator utilization rate   Ventilator days per 100 pd (median, IQR)       35.5     25.4--49.5
  UC utilization rate           UC days per 100 pd (median, IQR)               84.0     72.8--91.7
  Incidence density PBSI        PBSI/1000 pd (median, IQR)                     0.64     0.33--1.14

PBSI, primary bloodstream infection; CVC, central venous catheter; UC, urinary catheter; pd, patient days; IQR, interquartile range.

^a^ other than Medical-surgical, Surgical, Medical, Cardiothoracic, Neurosurgical, Neurological or Pediatric.

A total of 14,626 PBSI were recorded, that is, an incidence of 0.32 per 100 patients or 0.86 per 1000 patient days. 95% of the PBSI were CVC-associated and the proportion does not change during the study period. For 12,745 PBSI, only one pathogen was isolated from the blood culture (87.1%).

The overall ICU mortality was 18.6% for PBSI. Mortality in multi-microbial PBSI was 24.1% (RR = 1.29, 95%CI 1.17--1.43, p\<0.001 compared to mono-microbial PBSI).

Time in the ICU until onset of PBSI was in median 14 days and differs depending on the type of pathogen, PBSI were observed early in the case of *E*.*coli* (11 days) or *S*.*aureus* (12 days), but late if Klebsiella *spp*., non-albicans Candida *spp*. (both 16 days), *P*.*aeruginosa* (18 days) or *S*.*maltophilia* (19 days) were found.

[Table 2](#pone.0194210.t002){ref-type="table"} shows mortality following mono-microbial PBSI for the various risk groups, confounders and pathogens in ICU-KISS from 2006 to 2015. Significances were found for sex, age, type of ICU and hospital also for type of organisms, organism groups and multidrug resistance groups responsible.

10.1371/journal.pone.0194210.t002

###### Results of univariate analysis for mortality in intensive care units (ICU) following mono-microbial primary bloodstream infections (PBSI) according to the type of organism and further risk factors and confounders, ICU-KISS, 2006--2015.

![](pone.0194210.t002){#pone.0194210.t002g}

  Parameter                                               Category                                                 No. not died   No. died   Mortality (%)   p-value[^a^](#t002fn002){ref-type="table-fn"}
  ------------------------------------------------------- -------------------------------------------------------- -------------- ---------- --------------- -----------------------------------------------
  Patients with BSI                                       Total                                                    10369          2376       18.6             
  Type of organism                                        CNS                                                      3579           641        15.2            \<0.001
                                                          Enterococcus *spp*.                                      1636           471        22.4            \<0.001 
                                                          *S*. *aureus*                                            1522           338        18.2             0.573
                                                          *Candida albicans*                                       510            166        24.6            \<0.001 
                                                          *E*. *coli*                                              434            125        22.4            0.021 
                                                          Klebsiella *spp*.                                        498            102        17.0            0.290 
                                                          Enterobacter *spp*.                                      366            68         15.7            0.105 
                                                          *P*. *aeruginosa*                                        242            84         25.8            0.001 
                                                          non-albicans-Candida *spp*.                              172            64         27.1             0.001
                                                          Serratia *spp*.                                          162            27         14.3             0.121
                                                          Acinetobacter *spp*.                                     91             21         18.8            0.977 
                                                          Proteus *spp*.                                           72             12         14.3             0.304
                                                          *S*. *maltophilia*                                       48             19         28.4             0.041
                                                          Other organisms [^b^](#t002fn003){ref-type="table-fn"}   1037           238        18.7            0.981 
  Time to onset of infection                              Days (median)                                            14             14                         0.958 
  Gender                                                  Male                                                     6989           1541       18.1            0.017
  Age                                                     Years (median)                                           68             73                         \<0.001 
  Age group                                               ≤45 years                                                2563           273        9.6             \<0.001
                                                          46--55 years                                             1990           399        16.7            0.007 
                                                          56--65 years                                             3010           730        19.5             0.102
                                                          \>65 years                                               2806           974        25.8            \<0.001 
  CVC associated [^g^](#t002fn008){ref-type="table-fn"}   Yes                                                      9846           2276       18.8            0.089 
  Size of hospital                                        ≥600 beds                                                5372           1224       18.6            0.796 
  Size of ICU                                             ≥12 beds                                                 7264           1637       18.4             0.267
  Type of hospital                                        Tertiary care                                            4778           968        16.8            \<0.001
  Type of ICU                                             Interdisciplinary                                        4668           1098       19.0            0.292
                                                          Medical                                                  1437           417        22.5             \<0.001
                                                          Surgical                                                 2482           525        17.5             0.057
                                                          Neurosurgical                                            360            26         6.7              \<0.001
                                                          Cardiosurgical                                           437            157        26.4            \<0.001 
                                                          Neurological                                             215            23         9.7             \<0.001 
                                                          Pediatric                                                324            19         5.5             \<0.001 
                                                          Other [^h^](#t002fn009){ref-type="table-fn"}             446            111        19.9             0.426
  Year of BSI                                             2006                                                     687            157        18.6            0.426
                                                          2007                                                     784            159        16.9            0.975 
                                                          2008                                                     830            191        18.7            0.956 
                                                          2009                                                     958            197        17.1             0.147
                                                          2010                                                     1000           230        18.7            0.957 
                                                          2011                                                     1051           225        17.6             0.329
                                                          2012                                                     1120           251        18.3             0.736
                                                          2013                                                     1230           299        19.6            0.329 
                                                          2014                                                     1335           318        19.2            0.505 
                                                          2015                                                     1374           349        20.3            0.065 
  Season                                                  Winter (Dec-Feb)                                         2396           577        19.4            0.221
                                                          Spring (Mar-May)                                         2613           620        19.2             0.366
                                                          Summer (Jun-Aug)                                         2797           609        17.9             0.182
                                                          Autumn (Sep-Nov)                                         2563           570        18.2             0.457
  Pathogen groups                                         Gram-positive [^d^](#t002fn005){ref-type="table-fn"}     6737           1450       17.7            \<0.001
  (N = 11470)                                             Gram-negative [^e^](#t002fn006){ref-type="table-fn"}     1913           458        19.3            0.342 
                                                          Fungi [^f^](#t002fn007){ref-type="table-fn"}             682            230        25.2             \<0.001
  Multi-drug (MDR) resistance groups (N = 6065)           MDR [^c^](#t002fn004){ref-type="table-fn"}               779            265        25.4            \<0.001

No., number; CNS, Coagulase negative staphylococci; CVC, central venous catheter; pd, patient days.

^a^ p-values, Chi-square test or Wilcoxon rank sum test

^b^ other than the 13 most common organisms causing PBSI: coagulase negative Staphylococci (CNS), Enterococcus *spp*., *S*. *aureus*, *C*.*albicans*, non-albicans-Candida *spp*., *E*. *coli*, Klebsiella *spp*., Enterobacter *spp*., *P*. *aeruginosa*, Serratia *spp*., Acinetobacter *spp*., Proteus *spp*., and *S*. *maltophilia;*

^c^ MDR, Multi-drug resistance includes Methicillin resistant *S*.*aureus*, Vancomycin resistant *E*.*faecalis* and E.*faecium*, and multidrug resistance defined as a resistance to at least 3 antibiotic groups for *P*.*aeruginosa*, Acinetobacter *spp*., Enterobacter *spp*., *E*.*coli*, *S*.*maltophilia*, Klebsiella *spp*. and/or the resistance mechanisms ESBL for *Klebsiella pneumonia* and *E*.*coli*, MDR compared to Non-MDR, includes Vancomycin sensible Enterococcus *spp*., Methicillin sensible *S*. *aureus* and non-multi-drug resistance for *E*. *coli*, Klebsiella *spp*., Enterobacter *spp*., *P*. *aeruginosa*, Acinetobacter *spp*., *S*. *maltophilia*

^d^ includes coagulase negative Staphylococci (CNS), Enterococcus *spp*., *S*. *aureus;*

^e^ includes *E*. *coli*, Klebsiella *spp*., Enterobacter *spp*., *P*. *aeruginosa*, Serratia *spp*., Acinetobacter *spp*., Proteus *spp*., and *S*. *maltophilia;*

^f^ *C*. *albicans*, non-albicans-Candida spp.

^g^ device present \<48h before diagnosis of infection

^h^ other than Medical-surgical, Surgical, Medical, Cardiothoracic, Neurosurgical, Neurological or Pediatric.

ICU mortality following mono-microbial ICU-acquired PBSI for the type of pathogen is also illustrated in [Fig 1](#pone.0194210.g001){ref-type="fig"} and stratified according to the resistance of pathogen in [Fig 2](#pone.0194210.g002){ref-type="fig"}.

![ICU mortality in patients with ICU-acquired primary bloodstream infections according to the type of pathogen.\
ICU, intensive care unit; CNS, coagulase negative staphylococci; Whiskers represent 95% confidence interval.](pone.0194210.g001){#pone.0194210.g001}

![ICU mortality in patients with ICU-acquired primary bloodstream infection according to the type and resistance of pathogen.\
ICU, intensive care unit; MDR, Multi-drug resistance includes Methicillin resistant *S*.*aureus*, Vancomycin resistant *E*.*faecalis* and *E*.*faecium*, and multidrug resistance defined as a resistance to at least 3 antibiotic groups for *P*.*aeruginosa*, Acinetobacter *spp*., Enterobacter *spp*., *E*.*coli*, *S*.*maltophilia*, Klebsiella *spp*. and/or the resistance mechanisms ESBL for Klebsiella *spp*. and *E*.*coli*; Non-MDR, includes Vancomycin sensible Enterococcus *spp*., Methicillin sensible *S*. *aureus* and non-multi-drug resistance for *E*. *coli*, Klebsiella *spp*., Enterobacter *spp*., *P*. *aeruginosa*, Acinetobacter *spp*., *S*. *maltophilia*; Whiskers represent 95% confidence interval.](pone.0194210.g002){#pone.0194210.g002}

[Table 3](#pone.0194210.t003){ref-type="table"} and [Fig 3](#pone.0194210.g003){ref-type="fig"} show the results of the multivariable analysis for ICU mortality following PBSI of various pathogens compared to *S*.*aureus*. Adjusted by gender, age group and the type of ICU, Enterococci, *E*.*coli*, *C*.*albicans* and Non-albicans Candida *spp*., *S*. *maltophilia* and *P*.*aeruginosa* were associated with higher mortality compared to *S*.*aureus;* CNS with lower mortality respectively.

![Adjusted odds ratios (AOR) for ICU mortality in patients with ICU-acquired primary bloodstream infections according to the type of pathogen.\
ICU, intensive care unit; CNS, coagulase negative staphylococci; Whiskers represent 95% confidence interval; S. aureus was set as reference.](pone.0194210.g003){#pone.0194210.g003}

10.1371/journal.pone.0194210.t003

###### Results of multivariable analysis for mortality in intensive care units (ICU) following mono-microbial primary bloodstream infection (PBSI) according to type of organism and further risk factors and confounders, ICU-KISS, 2006--2015.

![](pone.0194210.t003){#pone.0194210.t003g}

  Parameter          Category                                       AOR             95%CI        p-value
  ------------------ ---------------------------------------------- --------------- ------------ ---------
  Type of organism   Coagulase negative staphylococci               0.86            0.75--0.99   0.030
                     Enterococcus *spp*.                            1.20            1.06--1.36   0.005
                     *Candida albicans*                             1.37            1.16--1.61   \<.0001
                     *E*. *coli*                                    1.24            1.02--1.49   0.029
                     Klebsiella *spp*.                              0.97            0.81--1.17   0.780
                     Enterobacter *spp*.                            0.93            0.74--1.18   0.556
                     *P*. *aeruginosa*                              1.49            1.21--1.84   \<.0001
                     *non-albicans-Candida spp*.                    1.49            1.18--1.88   0.001
                     Serratia spp.                                  0.74            0.52--1.06   0.105
                     Acinetobacter *spp*.                           1.22            0.86--1.74   0.262
                     Proteus *spp*.                                 0.77            0.46--1.3    0.324
                     *S*. *maltophilia*                             1.71            1.19--2.47   0.004
                     *S*. *aureus*                                  1 = reference                 
  Gender             Male                                           0.92            0.86--1      0.042
                     Female                                         1 = reference                 
  Age group          ≤45 years                                      0.46            0.4--0.52    \<.0001
                     46--55 years                                   0.70            0.62--0.78   \<.0001
                     56--65 years                                   0.79            0.72--0.86   \<.0001
                     \>65 years                                     1 = reference                 
  Type of ICU        Medical                                        1.12            0.95--1.32   0.161
                     Surgical                                       0.89            0.77--1.02   0.101
                     Neurosurgical                                  0.44            0.27--0.72   0.001
                     Cardiosurgical                                 1.48            1.18--1.85   0.001
                     Neurological                                   0.52            0.39--0.71   \<.0001
                     Paediatric                                     0.55            0.38--0.8    0.002
                     Other [^a^](#t003fn003){ref-type="table-fn"}   1.02            0.8--1.3     0.887
                     Interdisciplinary                              1 = reference                 

The multivariable analysis was performed using logistic regression analysis they were based on generalized estimating equation (GEE) models which account for this clustering effect by using an exchangeable correlation structure.

AOR, adjusted odds ratio; CI, confidence interval; ICU, intensive care unit.

^a^ other than Medical-surgical, Surgical, Medical, Cardiothoracic, Neurosurgical, Neurological or Pediatric.

[Table 4](#pone.0194210.t004){ref-type="table"} shows the results of the multivariable analysis for mortality following PBSI stratified by pathogen groups (gram-positive, gram-negative bacteria and fungi) and table [5](#pone.0194210.t005){ref-type="table"} by multi-drug resistance groups (non-multi-drug resistant/multi-drug resistant).

10.1371/journal.pone.0194210.t004

###### Results of multivariable analysis for mortality in intensive care units (ICU) following mono-microbial primary bloodstream infection (PBSI) according to group of organisms, ICU-KISS, 2006--2015.

![](pone.0194210.t004){#pone.0194210.t004g}

  Parameter            Category                                               OR              95%CI        p-value
  -------------------- ------------------------------------------------------ --------------- ------------ ---------
  Group of organisms   Gram-negative [^a^](#t004fn004){ref-type="table-fn"}   1.12            1.01--1.23   0.024
                       Fungi [^b^](#t004fn005){ref-type="table-fn"}           1.42            1.25--1.62   \<.0001
                       Gram-positive [^c^](#t004fn006){ref-type="table-fn"}   1 = reference                ** **
  Gender               Male                                                   0.92            0.85--0.99   0.036
                       Female                                                 1 = reference                
  Age group            ≤45 years                                              0.45            0.4--0.52    \<.0001
                       46--55 years                                           0.70            0.62--0.78   \<.0001
                       56--65 years                                           0.79            0.72--0.86   \<.0001
                       \>65 years                                             1 = reference                 
  Type of ICU          Medical                                                1.15            0.98--1.35   0.085
                       Surgical                                               0.89            0.77--1.02   0.102
                       Neurosurgical                                          0.43            0.26--0.69   0.001
                       Cardiosurgical                                         1.45            1.16--1.83   0.001
                       Neurological                                           0.52            0.39--0.7    \<.0001
                       Paediatric                                             0.53            0.36--0.77   0.001
                       Other [^d^](#t004fn007){ref-type="table-fn"}           1.05            0.82--1.34   0.708
                       Interdisciplinary                                      1 = reference                 

The multivariable analysis was performed using logistic regression analysis they were based on generalized estimating equation (GEE) models which account for this clustering effect by using an exchangeable correlation structure

OR, odds ratio; CI, confidence interval

Model is adjusted by age, sex and type of ICU

^a^ includes *E*. *coli*, Klebsiella *spp*., Enterobacter *spp*., *P*. *aeruginosa*, Serratia *spp*., Acinetobacter *spp*., Proteus *spp*., and *S*. *maltophilia*.

^b^ includes *C*. *albicans*, non-albicans-Candida spp.

^c^ includes coagulase negative Staphylococci, Enterococcus *spp*., *S*. *aureus;*

^d^ other than Medical-surgical, Surgical, Medical, Cardiothoracic, Neurosurgical, Neurological or Pediatric.

10.1371/journal.pone.0194210.t005

###### Results of multivariable analysis for mortality in intensive care units (ICU) following mono-microbial primary bloodstream infection (PBSI) according to multidrug resistance groups, ICU-KISS, 2006--2015.

![](pone.0194210.t005){#pone.0194210.t005g}

  Parameter                            Category                                         OR              95%CI        p-value
  ------------------------------------ ------------------------------------------------ --------------- ------------ ---------
  Multi-drug (MDR) resistance groups   MDR [^a^](#t005fn004){ref-type="table-fn"}       1.36            1.21--1.52   \<.0001
                                       Non-MDR [^b^](#t005fn005){ref-type="table-fn"}   1 = reference                
  Gender                               Male                                             0.91            0.84--0.98   0.017
                                       Female                                           1.00            1--1         0.000
  Age group                            ≤45 years                                        0.46            0.4--0.52    \<.0001
                                       46--55 years                                     0.70            0.63--0.78   \<.0001
                                       56--65 years                                     0.79            0.72--0.86   \<.0001
                                       \>65 years                                       1 = reference                
  Type of ICU                          Medical                                          1.15            0.98--1.35   0.097
                                       Surgical                                         0.92            0.8--1.06    0.236
                                       Neurosurgical                                    0.43            0.27--0.7    0.001
                                       Cardiosurgical                                   1.48            1.16--1.89   0.002
                                       Neurological                                     0.52            0.38--0.71   \<.0001
                                       Paediatric                                       0.54            0.38--0.79   0.001
                                       Other [^c^](#t005fn006){ref-type="table-fn"}     1.07            0.83--1.38   0.615
                                       Interdisciplinary                                1 = reference                

The multivariable analysis was performed using logistic regression analysis they were based on generalized estimating equation (GEE) models which account for this clustering effect by using an exchangeable correlation structure

OR, odds ratio; CI, confidence interval

Model is adjusted by age, sex and type of ICU

^a^ MDR, Multi-drug resistance includes Methicillin resistant *S*.*aureus*, Vancomycin resistant *E*.*faecalis* and *E*.*faecium*, and multidrug resistance defined as a resistance to at least 3 antibiotic groups for *P*.*aeruginosa*, Acinetobacter *spp*., Enterobacter *spp*., *E*.*coli*, *S*.*maltophilia*, Klebsiella *spp*. and/or the resistance mechanisms ESBL for Klebsiella *spp*. and *E*.*coli*

^b^ Non-MDR, includes Vancomycin sensible Enterococcus *spp*., Methicillin sensible *S*. *aureus* and non-multi-drug resistance for *E*. *coli*, Klebsiella *spp*., Enterobacter *spp*., *P*. *aeruginosa*, Acinetobacter *spp*., *S*. *maltophilia*

^c^ other than Medical-surgical, Surgical, Medical, Cardiothoracic, Neurosurgical, Neurological or Pediatric.

Discussion {#sec011}
==========

The present study evaluated ICU mortality after PBSI in relation to various types of pathogen in a large cohort of more than 4.5 Mio ICU patients. PBSI with Enterococci, *E*.*coli*, *C*.*albicans* and Non-albicans Candida *spp*., *S*. *maltophilia* and *P*.*aeruginosa* were associated with higher ICU mortality compared to *S*.*aureus*, CNS were associated with significant lower ICU mortality.

The significantly higher ICU mortality rates following PBSI with *E*.*coli* and Enterococci have not been previously described and seem to be particularly interesting. Only a recent article by Ong et al. also associated enterococci PBSI with significantly higher mortality rates \[[@pone.0194210.ref007]\]. These authors used data from two ICUs in the Netherlands, considered ICU discharge and death as competing events. The occurrence of enterococcal bacteremia (not only PBSI) was fitted as a time time-dependent variable. The authors of this study argue that the high risk of death following entercoccal bacteremia may be a marker of impending complications that carry high risk of death in the ICU rather than being causes of death on their own. For instance, the higher mortality in Enterococci PBSI (and also *E*.*coli*) may originate in translocation from the digestive tract of patients in unstable hemodynamic conditions, such as during shock or the support of ECMO. The higher mortality of E.coli cannot be explained by the percentage of multi-drug resistant E.coli. (ICU mortality non-MDR E.coli 20.9, mortality MDR-E.coli 31.3).

Our results confirm findings from earlier studies concerning Candida *spp*. and *P*.*aeruginosa* which are known for a high mortality. In the past, Candida *spp*. was often described as leading to higher mortality. In an analysis of more than 6000 patients with BSI, Shorr et al. demonstrated that fungal organisms were associated with the highest mortality \[[@pone.0194210.ref014]\]. In a review, the same authors described infections caused by mixed resistant Gram-negative bacteria, extended-spectrum beta-lactamase-producing Enterobacteriaceae, multi-drug resistant *Pseudomonas aeruginosa*, and Acinetobacter species as being generally associated with increased mortality \[[@pone.0194210.ref001]\]. Lambert et al. described a very high mortality rate following *P*.*aeruginosa* PBSI in European ICU patients \[[@pone.0194210.ref005]\]. A recent cohort study from North Carolina reported that *P*.*aeruginosa* remained significantly associated with increased mortality following BSI relative to *S*.*aureus* and other gram-negative bacteria (Hazard ratio 1.43, p = 0.02) \[[@pone.0194210.ref015]\]. In another study from US hospitals that focused on severe sepsis, anaerobes and Methicillin-resistant *S*.*aureus* were significant predictors of mortality whereas Gram-negative bacteria had decreased mortality hazards \[[@pone.0194210.ref003]\].

According to a recent study with data from more than 600,000 in patients from 10 European hospitals, which focussed on all BSI due to *S*.*aureus* and Enterobacteriaceae and also considered competing risks, *S*.*aureus* had a greater impact on mortality than Enterobacteriacae. However, the authors pooled the data for all Enterobacteriacae and did not focus individual species such as *E*.*coli* \[[@pone.0194210.ref008]\]. In our study *E*.*coli* mortality was higher than Klebsiella *spp*., Enterobacter *spp*., Proteus *spp*. and Serratia *spp*..

Many authors have compared the mortality rates of the susceptible and resistant variants of the pathogens causing infections \[[@pone.0194210.ref005], [@pone.0194210.ref016]--[@pone.0194210.ref019]\]. We also tried to show the differences between the two groups of pathogens. But we must point out that we were not able to adjust for underlying diseases which seem to be a very important risk factor for multi-drug resistant bacteria. Only the time, from admission until onset of infection, could be considered, which may be a surrogate parameter for severity of illness. This is one of the most important limitations of our analysis. For example PBSI with *S*.*maltophilia* occur after a long stay on ICU (Median 19 days). However, the time to BSI was not significant in the multivariable analysis.

Our analysis has further limitations. First, our analysis only represents ICU mortality following ICU-acquired primary BSI. No BSI within the first three days on ICU or secondary BSI are included. Second, autopsies are very rarely performed in German ICUs, thus also precluding confirmation of a direct relationship between mortality and PBSI. Third, only mortality in the ICU was observed, but not during subsequent hospital stays. Fourth, it is impossible to provide information about the sensitivity of recording the death of the patients, but due to the use of web-based surveillance systems, the surveillance staff cannot complete an infection case without entering this information. Fifth, the analysis concentrates only on mono-microbial infections; mortality following poly-microbial infections was significantly higher. Sixthly, usually the time to event has been used to account for the risk of death, but because the time to the event "death" was not available for infected patients, such an analysis was not possible. Finally, the database does not include any information about the underlying diseases of the patients and empirical antimicrobial therapy (substances and the timing of antibiotics). Therefore, adjustment related to inappropriate initial antimicrobial therapy is impossible.

Conclusion {#sec012}
==========

In summary, out data shows substantial differences in mortality in German ICUs according to the type of pathogen. Considering the aggressive nature of the pathogens identified with significantly higher mortality rates, information on the type of pathogen is itself important for the prognosis of patients. Therefore, taking blood cultures is important and their results should be provided to clinicians as soon as possible.

Data have been generated as part of the routine work of the nosocomial hospital infection surveillance system (KISS). Special thanks to the healthcare staff and the infection control personnel of all ICU-KISS units for their participation, their support of the surveillance project. A part of this study was presented at the congress Sepsis Update in Weimar, Germany 2015.
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